Back to Search Start Over

[Progress in perioperative management of ABO-incompatible pediatric liver transplantation].

Authors :
Yu H
Wang WL
Zhang W
Bai XL
Liang TB
Source :
Zhonghua wai ke za zhi [Chinese journal of surgery] [Zhonghua Wai Ke Za Zhi] 2023 Feb 01; Vol. 61 (2), pp. 173-176.
Publication Year :
2023

Abstract

ABO incompatible(ABO-I) liver grafts will affect the prognosis of liver transplantation. With the improvement of perioperative treatment,including plasma exchange,rituximab,splenectomy,etc.,the prognosis of ABO-I liver transplantation has been greatly improved. Because children's immune systems are not fully developed,the perioperative management of ABO-I pediatric liver transplantation is significantly different from that of adults. Reducing the perioperative anti-donor ABO antibody titer is the key to the perioperative management of ABO-I liver transplantation. This article summarizes literatures on the perioperative management of ABO-I pediatric liver transplantation, including the perioperative anti-rejection regimen in pediatric recipients of different ages, splenectomy, postoperative monitoring and postoperative complications, etc.

Details

Language :
Chinese
ISSN :
0529-5815
Volume :
61
Issue :
2
Database :
MEDLINE
Journal :
Zhonghua wai ke za zhi [Chinese journal of surgery]
Publication Type :
Academic Journal
Accession number :
36720628
Full Text :
https://doi.org/10.3760/cma.j.cn112139-20220507-00206